Centesis Catheters Market to Reach $633 million by 2025

What This Report Will Provide? This study involved four major activities in estimating the current size of the centesis catheters market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Expected Revenue Growth: [155 Pages Report] The global centesis catheters market is projected to reach USD 633 million by 2025 from USD 426 million in 2019, at a CAGR of 6.8%.

Major Growth Boosters: Growth in the global centesis catheters market can be attributed to factors such as the rising target patient population (particularly patients suffering from cancer, TB, and cardiovascular diseases), growing preference for image-guided centesis procedures, and the increasing evidence for the efficacy of centesis procedures for target diseases.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=254850580

Recent Developments: In 2019, Galt Medical Corp (US) acquired Arrotek Medical Limited (Ireland) that expanded the former’s minimally invasive devices portfolio.

In 2019, Merit Medical (US) launched the ReSolve Mini Locking Drainage Catheter with a 42% smaller pigtail design (as compared to the other ReSolve Mini drainage catheters offered by the company).

In 2017, Teleflex Incorporated (US) acquired Vascular Solutions, Inc. (US).

In 2017, Cardinal Health (US) acquired the Patient Care, Deep Vein Thrombosis, and Nutrient Insufficiency business lines from Medtronic, plc (Ireland).

Regional Growth Analysis: Geographically, this market is classified into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2018, North America was the largest regional market for centesis catheters. This can primarily be attributed to the high number of cardiovascular, neurovascular, and other target procedures performed in the region. Factors such as the large patient pool, the presence of a well-established healthcare system, and on-going investments by hospitals to upgrade their operating rooms are driving the growth of this regional market.

Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global centesis catheters market?
2. What are the drivers, restraints, opportunities, and challenges in the centesis catheters Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of centesis catheters in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=254850580

Key Players: The key players operating in the global centesis catheters market are AngioDynamics, Inc. (US), ARGON MEDICAL (US), Avanos Medical Devices (US), Axiom Medical, Inc. (US), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (US), Blue Neem Medical Devices Pvt. Ltd. (India), Boston Scientific Corporation (US), Canadian Hospital Specialties Ltd. (Canada), Cardinal Health (US), Cook Medical (US), Galt Medical Corp. (US), Guangzhou Leadgem Medical Device Co., Ltd. (China), KM Medical (US)